Page last updated: 2024-08-24

n 0437, (-)-isomer and Erythema

n 0437, (-)-isomer has been researched along with Erythema in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alba-Alcántara, L; Bermejo, PE; Ruiz-Huete, C; Zea, MA1
LeWitt, PA; Lyons, KE; Pahwa, R1

Trials

1 trial(s) available for n 0437, (-)-isomer and Erythema

ArticleYear
Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study.
    Neurology, 2007, Apr-17, Volume: 68, Issue:16

    Topics: Administration, Cutaneous; Aged; Dopamine Agonists; Double-Blind Method; Drug Administration Routes; Drug Administration Schedule; Dyskinesia, Drug-Induced; Erythema; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pruritus; Tetrahydronaphthalenes; Thiophenes; Time Factors; Treatment Outcome

2007

Other Studies

1 other study(ies) available for n 0437, (-)-isomer and Erythema

ArticleYear
[Local effects of transdermal treatment with rotigotine].
    Revista de neurologia, 2013, Apr-01, Volume: 56, Issue:7

    Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Drug Evaluation; Drug Therapy, Combination; Equipment Failure; Erythema; Female; Humans; Male; Middle Aged; Pain; Patient Acceptance of Health Care; Retrospective Studies; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch

2013